Comparison Overview

AstraZeneca

VS

SUN PHARMA

AstraZeneca

1 Francis Crick Avenue, Cambridge, CB2 0AA, GB
Last Update: 2025-12-11
Between 800 and 849

We're transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet. For more information, visit www.astrazeneca.com. Community Guidelines: bit.ly/2MgAcio

NAICS: 3254
NAICS Definition: Pharmaceutical and Medicine Manufacturing
Employees: 77,114
Subsidiaries: 0
12-month incidents
0
Known data breaches
1
Attack type number
1

SUN PHARMA

Sun House, CTS No. 201 B/1,, Mumbai, 400063, IN
Last Update: 2025-12-10
Between 800 and 849

Sun Pharma is the world's fourth-largest speciality generic pharmaceutical company and No. 1 in India. We provide high-quality, affordable medicines trusted by customers and patients in over 100 countries. Sun Pharma's global presence is supported by more than 40 manufacturing facilities spread across 5 continents, R&D centres across the globe, and a multicultural workforce comprising over 50 nationalities. Sun Pharma fosters excellence through innovation supported by strong R&D capabilities comprising around 3,000 scientists and R&D investments of over 6-8% of annual revenues. At Sun, our people are our greatest asset. Ours has never been a story of individual brilliance but of cultivating a culture of realising collective potential. In our journey, everyone is enabled to take charge in an environment that offers limitless growth opportunities. We are with you every step of the way, so you can shine for years to come. With the launch of our Employee Value Proposition (EVP), we define our promise to ‘Create Your Own Sunshine'—driven by the three pillars of Better Every Day, Take Charge, and Thrive Together. These pillars drive progress at Sun so that people can achieve what they would have thought impossible. Learn more about our EVP here: https://sunpharma.com/careers/

NAICS: 3254
NAICS Definition: Pharmaceutical and Medicine Manufacturing
Employees: 43,552
Subsidiaries: 1
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/astrazeneca.jpeg
AstraZeneca
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/sun-pharma.jpeg
SUN PHARMA
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
AstraZeneca
100%
Compliance Rate
0/4 Standards Verified
SUN PHARMA
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)

No incidents recorded for AstraZeneca in 2025.

Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)

No incidents recorded for SUN PHARMA in 2025.

Incident History — AstraZeneca (X = Date, Y = Severity)

AstraZeneca cyber incidents detection timeline including parent company and subsidiaries

Incident History — SUN PHARMA (X = Date, Y = Severity)

SUN PHARMA cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/astrazeneca.jpeg
AstraZeneca
Incidents

Date Detected: 6/2021
Type:Breach
Attack Vector: Exposed Credentials
Blog: Blog
https://images.rankiteo.com/companyimages/sun-pharma.jpeg
SUN PHARMA
Incidents

No Incident

FAQ

AstraZeneca company demonstrates a stronger AI Cybersecurity Score compared to SUN PHARMA company, reflecting its advanced cybersecurity posture governance and monitoring frameworks.

AstraZeneca company has historically faced a number of disclosed cyber incidents, whereas SUN PHARMA company has not reported any.

In the current year, SUN PHARMA company and AstraZeneca company have not reported any cyber incidents.

Neither SUN PHARMA company nor AstraZeneca company has reported experiencing a ransomware attack publicly.

AstraZeneca company has disclosed at least one data breach, while the other SUN PHARMA company has not reported such incidents publicly.

Neither SUN PHARMA company nor AstraZeneca company has reported experiencing targeted cyberattacks publicly.

Neither AstraZeneca company nor SUN PHARMA company has reported experiencing or disclosing vulnerabilities publicly.

Neither AstraZeneca nor SUN PHARMA holds any compliance certifications.

Neither company holds any compliance certifications.

SUN PHARMA company has more subsidiaries worldwide compared to AstraZeneca company.

AstraZeneca company employs more people globally than SUN PHARMA company, reflecting its scale as a Pharmaceutical Manufacturing.

Neither AstraZeneca nor SUN PHARMA holds SOC 2 Type 1 certification.

Neither AstraZeneca nor SUN PHARMA holds SOC 2 Type 2 certification.

Neither AstraZeneca nor SUN PHARMA holds ISO 27001 certification.

Neither AstraZeneca nor SUN PHARMA holds PCI DSS certification.

Neither AstraZeneca nor SUN PHARMA holds HIPAA certification.

Neither AstraZeneca nor SUN PHARMA holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

FreePBX Endpoint Manager is a module for managing telephony endpoints in FreePBX systems. Versions prior to 16.0.96 and 17.0.1 through 17.0.9 have a weak default password. By default, this is a 6 digit numeric value which can be brute forced. (This is the app_password parameter). Depending on local configuration, this password could be the extension, voicemail, user manager, DPMA or EPM phone admin password. This issue is fixed in versions 16.0.96 and 17.0.10.

Risk Information
cvss4
Base: 6.9
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

Neuron is a PHP framework for creating and orchestrating AI Agents. In versions 2.8.11 and below, the MySQLWriteTool executes arbitrary SQL provided by the caller using PDO::prepare() + execute() without semantic restrictions. This is consistent with the name (“write tool”), but in an LLM/agent context it becomes a high-risk capability: prompt injection or indirect prompt manipulation can cause execution of destructive queries such as DROP TABLE, TRUNCATE, DELETE, ALTER, or privilege-related statements (subject to DB permissions). Deployments that expose an agent with MySQLWriteTool enabled to untrusted input and/or run the tool with a DB user that has broad privileges are impacted. This issue is fixed in version 2.8.12.

Risk Information
cvss3
Base: 9.4
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:H
Description

Neuron is a PHP framework for creating and orchestrating AI Agents. Versions 2.8.11 and below use MySQLSelectTool, which is vulnerable to Read-Only Bypass. MySQLSelectTool is intended to be a read-only SQL tool (e.g., for LLM agent querying, however, validation based on the first keyword (e.g., SELECT) and a forbidden-keyword list does not block file-writing constructs such as INTO OUTFILE / INTO DUMPFILE. As a result, an attacker who can influence the tool input (e.g., via prompt injection through a public agent endpoint) may write arbitrary files to the DB server if the MySQL/MariaDB account has the FILE privilege and server configuration permits writes to a useful location (e.g., a web-accessible directory). This issue is fixed in version 2.8.12.

Risk Information
cvss3
Base: 8.2
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:N
Description

Okta Java Management SDK facilitates interactions with the Okta management API. In versions 11.0.0 through 20.0.0, race conditions may arise from concurrent requests using the ApiClient class. This could cause a status code or response header from one request’s response to influence another request’s response. This issue is fixed in version 20.0.1.

Risk Information
cvss3
Base: 8.4
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:C/C:H/I:H/A:L
Description

The Auth0 Next.js SDK is a library for implementing user authentication in Next.js applications. When using versions 4.11.0 through 4.11.2 and 4.12.0, simultaneous requests on the same client may result in improper lookups in the TokenRequestCache for the request results. This issue is fixed in versions 4.11.2 and 4.12.1.

Risk Information
cvss3
Base: 5.4
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:R/S:U/C:H/I:L/A:N